Workflow
仿制药原料药及中间体
icon
Search documents
天宇股份:9月29日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-29 11:52
Group 1 - Tianyu Co., Ltd. (SZ 300702) held its 15th meeting of the 5th board of directors on September 29, 2025, to discuss the proposal for the extension of certain fundraising investment projects [1] - For the first half of 2025, Tianyu's revenue composition was as follows: 72.18% from generic drug raw materials and intermediates, 16.02% from CDMO raw materials and intermediates, 11.43% from formulations, and 0.37% from others [1] - As of the report date, Tianyu's market capitalization was 8.9 billion yuan [1] Group 2 - The competition between Farmer and Yibao has intensified, with Farmer's green bottle launch leading to a nearly 5 percentage point drop in Yibao's market share [1]
天宇股份股价微跌0.11% 机构调研透露上半年营收增长23.87%
Jin Rong Jie· 2025-08-25 17:40
Group 1 - Tianyu Co., Ltd. stock price on August 25 was 27.57 yuan, a decrease of 0.03 yuan or 0.11% from the previous trading day [1] - The opening price on the same day was 27.45 yuan, with a highest point of 27.80 yuan and a lowest point of 27.20 yuan, achieving a trading volume of 243 million yuan and a turnover rate of 4.18% [1] - The company operates in the chemical pharmaceutical sector, focusing on generic drug raw materials and intermediates, CDMO raw materials and intermediates, and formulations [1] Group 2 - In the first half of 2025, the company achieved operating revenue of 1.567 billion yuan, representing a year-on-year growth of 23.87%, with a gross profit margin increase to 38% [1] - On August 24, the company hosted a research meeting with several institutions including Huachuang Securities, CICC, and CITIC Securities, where executives discussed the operating conditions of the first half of the year and addressed investor concerns [1] - On August 25, the net outflow of main funds from the company was 2.5081 million yuan, accounting for 0.04% of the circulating market value, while the net inflow over the past five days was 48.9456 million yuan, representing 0.84% of the circulating market value [1]
天宇股份:2025年半年度计提各项资产减值准备金额累计7216.42万元
Mei Ri Jing Ji Xin Wen· 2025-08-22 15:29
Group 1 - Tianyu Co., Ltd. announced a total asset impairment provision of 72.1642 million yuan for the first half of 2025, in compliance with accounting standards and relevant policies [1] - The company's revenue composition for the first half of 2025 includes 72.18% from generic drug raw materials and intermediates, 16.02% from CDMO raw materials and intermediates, 11.43% from formulations, and 0.37% from other sources [1] - As of the announcement, Tianyu Co., Ltd. has a market capitalization of 9.6 billion yuan [1]